These Analysts Boost Their Forecasts On Ethos Technologies Following Upbeat Q2 Results
Ethos Technologies Inc (NASDAQ: LIFE ) on Monday reported better-than-expected second-quarter financial results and raised its FY26 sales guidance above estimates. Ethos Technologies reported quarterly earnings of 53 cents per share which beat the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $189.562 million which beat the analyst consensus estimate of $117.306 million. Ethos Technologies raised its FY2026 sales guidance from $561.000 million-$565.000 million to $727.000 million-$731.000 million. “Q2 was our second consecutive quarter of over 100% year-over-year growth, extending a streak of durable, multi-year growth we’ve built quarter over quarter,” said Peter Colis, CEO and Co-Founder of Ethos. “In Q2 alone, we protected more than 100,000 additional families at a pace that shows just how fast our growth is compou...
Ethos Technologies Inc (NASDAQ: LIFE ) on Monday reported better-than-expected second-quarter financial results and raised its FY26 sales guidance above estimates.
Ethos Technologies reported quarterly earnings of 53 cents per share which beat the analyst consensus estimate of 26 cents per share.
The company reported quarterly sales of $189.562 million which beat the analyst consensus estimate of $117.306 million.
Ethos Technologies raised its FY2026 sales guidance from $561.000 million-$565.000 million to $727.000 million-$731.000 million. “Q2 was our second consecutive quarter of over 100% year-over-year growth, extending a streak of durable, multi-year growth we’ve built quarter over quarter,” said Peter Colis, CEO and Co-Founder of Ethos. “In Q2 alone, we protected more than 100,000 additional families at a pace that shows just how fast our growth is compounding.” Ethos Technologies shares jumped 20.1% to $27.41 in pre-market trading.
These analysts made changes to their price targets on Ethos Technologies following earnings announcement.
Baird analyst Colin Sebastian maintained the stock with an Outperform rating and raised the price target from $26 to $32.
Barclays analyst Ross Sandler maintained the stock with an Overweight rating and raised the price target from $27 to $37.
Considering buying LIFE stock? Here’s what analysts think: Photo via Shutterstock